IL288044A - Preparations containing ephardin or ephardin salt and methods for their preparation and use - Google Patents
Preparations containing ephardin or ephardin salt and methods for their preparation and useInfo
- Publication number
- IL288044A IL288044A IL288044A IL28804421A IL288044A IL 288044 A IL288044 A IL 288044A IL 288044 A IL288044 A IL 288044A IL 28804421 A IL28804421 A IL 28804421A IL 288044 A IL288044 A IL 288044A
- Authority
- IL
- Israel
- Prior art keywords
- ephedrine
- compositions
- making
- methods
- same
- Prior art date
Links
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 title 3
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 title 1
- 229960002179 ephedrine Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962849125P | 2019-05-16 | 2019-05-16 | |
| PCT/US2020/033310 WO2020232424A1 (en) | 2019-05-16 | 2020-05-16 | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL288044A true IL288044A (en) | 2022-01-01 |
Family
ID=73230956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL288044A IL288044A (en) | 2019-05-16 | 2021-11-11 | Preparations containing ephardin or ephardin salt and methods for their preparation and use |
Country Status (10)
| Country | Link |
|---|---|
| US (7) | US11090278B2 (https=) |
| EP (1) | EP3968975A4 (https=) |
| JP (3) | JP2022532657A (https=) |
| KR (2) | KR20240096847A (https=) |
| CN (1) | CN113825500A (https=) |
| AU (1) | AU2020276619A1 (https=) |
| CA (1) | CA3140043A1 (https=) |
| IL (1) | IL288044A (https=) |
| MX (1) | MX2021013888A (https=) |
| WO (1) | WO2020232424A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022532657A (ja) | 2019-05-16 | 2022-07-15 | ネクサス ファーマシューティカルズ， インコーポレイテッド | エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法 |
| US10869845B1 (en) | 2020-01-22 | 2020-12-22 | Nevakar Inc. | Ephedrine compositions and methods |
| US20230172840A1 (en) * | 2021-12-05 | 2023-06-08 | Fresenius Kabi Austria Gmbh | Ephedrine liquid formulations |
| CN120241601B (zh) * | 2025-06-04 | 2025-08-22 | 成都苑东生物制药股份有限公司 | 盐酸麻黄碱注射液及其制剂工艺 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK339289D0 (da) | 1989-07-07 | 1989-07-07 | Dak Lab As | Farmaceutisk praeparat |
| US7149574B2 (en) * | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
| FR2890316B1 (fr) | 2005-09-02 | 2007-10-05 | Aguettant Soc Par Actions Simp | Seringue destinee a etre remplie puis sterilisee par autoclavage a la vapeur. |
| FR2896168B1 (fr) | 2006-01-19 | 2008-10-17 | Aguettant Soc Par Actions Simp | Seringue hypodermique preremplie equipee d'un dispositif de bouchage |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| KR101906132B1 (ko) * | 2010-07-17 | 2018-10-10 | 메르크 파텐트 게엠베하 | 침투 및 작용의 증진 |
| FR2963237B1 (fr) | 2010-07-28 | 2013-05-17 | Aguettant Lab | Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain |
| CA2828635C (en) * | 2011-03-04 | 2020-01-14 | Grunenthal Gmbh | Parenteral administration of tapentadol |
| FR2992222B1 (fr) | 2012-06-22 | 2015-06-19 | Aguettant Lab | Dispositif de protection destine a equiper un dispositif d’injection pourvu d’un embout de raccordement |
| US10092701B2 (en) * | 2014-05-19 | 2018-10-09 | Medicom Innovation Partner A/S | Medical cartridge comprising a one way valve |
| ES2770731T3 (es) * | 2014-08-28 | 2020-07-02 | Sun Pharmaceutical Ind Ltd | Forma de dosificación parenteral de norepinefrina |
| FR3053893B1 (fr) | 2016-07-13 | 2018-07-27 | Laboratoire Aguettant | Dispositif medical comportant un emballage et une seringue pre-remplie disposee dans l’emballage |
| CA3051467C (en) * | 2017-01-30 | 2022-11-29 | Nevakar, Inc | Norepinephrine compositions and methods therefor |
| WO2019177725A1 (en) | 2018-03-13 | 2019-09-19 | Nevakar Inc. | Prefilled syringe, compositions and methods |
| FR3084263B1 (fr) | 2018-07-27 | 2020-07-10 | Laboratoire Aguettant | Systeme d’administration comportant un dispositif d’administration et un dispositif de protection pourvu d’une membrane de fermeture |
| JP2022532657A (ja) | 2019-05-16 | 2022-07-15 | ネクサス ファーマシューティカルズ， インコーポレイテッド | エフェドリンまたはエフェドリン塩を含む組成物ならびにその組成物を作製する方法および使用する方法 |
| US10869845B1 (en) | 2020-01-22 | 2020-12-22 | Nevakar Inc. | Ephedrine compositions and methods |
-
2020
- 2020-05-16 JP JP2021568373A patent/JP2022532657A/ja active Pending
- 2020-05-16 MX MX2021013888A patent/MX2021013888A/es unknown
- 2020-05-16 US US16/876,020 patent/US11090278B2/en active Active
- 2020-05-16 CN CN202080036184.0A patent/CN113825500A/zh active Pending
- 2020-05-16 AU AU2020276619A patent/AU2020276619A1/en not_active Abandoned
- 2020-05-16 CA CA3140043A patent/CA3140043A1/en active Pending
- 2020-05-16 KR KR1020247019305A patent/KR20240096847A/ko active Pending
- 2020-05-16 KR KR1020217040545A patent/KR102675027B1/ko active Active
- 2020-05-16 EP EP20805983.2A patent/EP3968975A4/en active Pending
- 2020-05-16 WO PCT/US2020/033310 patent/WO2020232424A1/en not_active Ceased
-
2021
- 2021-07-21 US US17/381,770 patent/US11464752B2/en active Active
- 2021-09-02 US US17/465,697 patent/US11241400B2/en active Active
- 2021-11-11 IL IL288044A patent/IL288044A/en unknown
- 2021-12-20 US US17/556,904 patent/US11426369B2/en active Active
-
2022
- 2022-05-06 US US17/738,557 patent/US11478436B2/en active Active
- 2022-09-12 US US17/943,185 patent/US11571398B1/en active Active
- 2022-10-10 US US17/962,626 patent/US20230068187A1/en active Pending
-
2023
- 2023-05-15 JP JP2023079995A patent/JP2023091072A/ja not_active Withdrawn
-
2025
- 2025-02-21 JP JP2025026685A patent/JP2025071269A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240096847A (ko) | 2024-06-26 |
| US11464752B2 (en) | 2022-10-11 |
| US20210353561A1 (en) | 2021-11-18 |
| US20210393552A1 (en) | 2021-12-23 |
| US11090278B2 (en) | 2021-08-17 |
| AU2020276619A1 (en) | 2021-12-16 |
| US11241400B2 (en) | 2022-02-08 |
| US11478436B2 (en) | 2022-10-25 |
| CN113825500A (zh) | 2021-12-21 |
| JP2025071269A (ja) | 2025-05-02 |
| WO2020232424A1 (en) | 2020-11-19 |
| US20200360309A1 (en) | 2020-11-19 |
| US20220265580A2 (en) | 2022-08-25 |
| US20230068187A1 (en) | 2023-03-02 |
| EP3968975A4 (en) | 2023-02-15 |
| JP2022532657A (ja) | 2022-07-15 |
| KR20220009985A (ko) | 2022-01-25 |
| EP3968975A1 (en) | 2022-03-23 |
| JP2023091072A (ja) | 2023-06-29 |
| US20220257539A1 (en) | 2022-08-18 |
| US11426369B2 (en) | 2022-08-30 |
| MX2021013888A (es) | 2022-01-24 |
| KR102675027B1 (ko) | 2024-06-14 |
| US20230025407A1 (en) | 2023-01-26 |
| CA3140043A1 (en) | 2020-11-19 |
| US20220110892A1 (en) | 2022-04-14 |
| US11571398B1 (en) | 2023-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277146A (en) | Amino acid compounds and methods of use | |
| IL288044A (en) | Preparations containing ephardin or ephardin salt and methods for their preparation and use | |
| SG11202100533VA (en) | Hepato-biliary-pancreatic tissues and methods of making same | |
| IL282026A (en) | Amino acid compounds and methods of use | |
| SG11202101814RA (en) | Compositions of cxcr4 inhibitors and methods of preparation and use | |
| IL275694A (en) | Unnatural nucleotide compounds and methods of using them | |
| IL285117A (en) | Methods for characterizing properties related to condensation of compounds and their uses | |
| IL276135A (en) | Preparations and methods of use | |
| ZA202004531B (en) | Compositions containing thymohydroquinone and their method of preparation | |
| SG11202009315WA (en) | Formulation and method of preparation | |
| ZA202100780B (en) | Bismuth-thiol compositions and methods of use | |
| ZA202108987B (en) | 1-amino-1-cyclopropanecarboxylic acid hudrochloride formulations | |
| SI3675816T1 (sl) | Anestetični sestavki z zadržanim sproščanjem in postopki za njihovo pripravo | |
| SG11202011227VA (en) | Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof | |
| EP3302099A4 (en) | Enhanced salt compositions and methods of preparation thereof | |
| ZA202004055B (en) | Salt of phenylpropionamide derivative and preparation method therefor | |
| IL273699A (en) | Sulfazine salt preparations and methods of using them | |
| PT3725786T (pt) | Forma cristalina e forma salina de inibidor de tgf-bri e método de preparação das mesmas | |
| IL274274A (en) | Salt form and crystal form of compound as FGFR4 inhibitor and method of their preparation | |
| HK40065278A (en) | Nanotransposon compositions and methods of use | |
| GB201906748D0 (en) | Method of formulation | |
| HK40049684A (en) | Bismuth-thiol compositions and methods of use | |
| HK40038994A (en) | Unnatural base pair compositions and methods of use | |
| HK40042765B (en) | Sirt1-sarna compositions and methods of use | |
| HK40042765A (en) | Sirt1-sarna compositions and methods of use |